Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
144
4.220
Why?
Vulvar Neoplasms
6
2024
60
2.610
Why?
Carcinoma, Squamous Cell
9
2024
330
2.090
Why?
Carcinoma in Situ
7
2022
72
1.830
Why?
Uterine Neoplasms
10
2023
59
1.830
Why?
Carcinoma, Endometrioid
6
2021
38
1.520
Why?
Adenocarcinoma
10
2024
404
1.470
Why?
Tumor Suppressor Protein p53
3
2024
224
1.390
Why?
PAX2 Transcription Factor
7
2015
24
1.350
Why?
Ovarian Neoplasms
10
2024
460
1.110
Why?
Uterine Cervical Neoplasms
7
2024
299
1.110
Why?
Endometrial Hyperplasia
4
2019
14
1.070
Why?
Cannabidiol
6
2024
43
1.030
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
62
1.020
Why?
Stromal Cells
2
2016
77
0.960
Why?
Female
66
2024
28236
0.860
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.840
Why?
Plant Extracts
6
2024
193
0.830
Why?
Myometrium
2
2013
13
0.800
Why?
Endometrium
6
2023
43
0.770
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.730
Why?
Precancerous Conditions
3
2019
85
0.710
Why?
Immunohistochemistry
16
2024
981
0.710
Why?
Cannabis
6
2024
150
0.700
Why?
Aged, 80 and over
20
2024
3417
0.670
Why?
Middle Aged
35
2024
13094
0.650
Why?
Humans
70
2024
52539
0.650
Why?
Cystadenocarcinoma, Serous
4
2013
73
0.650
Why?
Peripheral Nerves
2
2015
44
0.590
Why?
Mutation
9
2024
1342
0.560
Why?
Aged
29
2024
10197
0.550
Why?
Placenta
6
2021
153
0.530
Why?
Cervix Uteri
2
2017
49
0.530
Why?
Epithelial-Mesenchymal Transition
2
2016
57
0.520
Why?
Adult
31
2024
14160
0.520
Why?
Adenosarcoma
1
2016
3
0.510
Why?
Polyps
1
2016
21
0.500
Why?
Uterine Cervical Dysplasia
1
2016
51
0.490
Why?
Lymphatic Metastasis
6
2019
211
0.480
Why?
Neoplasm Staging
9
2024
767
0.470
Why?
Papillomavirus Infections
3
2024
172
0.470
Why?
Fallopian Tubes
2
2012
23
0.470
Why?
Fibroma
1
2015
40
0.470
Why?
Tumor Microenvironment
4
2021
254
0.460
Why?
Prognosis
11
2024
2116
0.420
Why?
Neoplasm Invasiveness
6
2019
278
0.420
Why?
Observer Variation
4
2024
132
0.410
Why?
Pelvic Neoplasms
1
2011
13
0.370
Why?
Uterus
3
2023
88
0.360
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
78
0.360
Why?
Mice, Inbred C57BL
7
2024
1897
0.340
Why?
Ejaculatory Ducts
1
2010
3
0.340
Why?
Seminal Vesicles
1
2010
13
0.330
Why?
Spectrum Analysis, Raman
2
2021
42
0.330
Why?
Neoplasm Recurrence, Local
4
2015
642
0.330
Why?
Reproducibility of Results
5
2024
1216
0.330
Why?
Prostate
1
2010
117
0.320
Why?
Bromcresol Purple
1
2009
3
0.310
Why?
Electrophoresis, Capillary
1
2009
10
0.310
Why?
Mice
16
2024
5944
0.310
Why?
Serum Albumin
1
2009
58
0.300
Why?
Human papillomavirus 16
2
2021
44
0.300
Why?
Methionine
2
2020
136
0.290
Why?
beta Catenin
2
2021
103
0.290
Why?
Predictive Value of Tests
5
2024
949
0.290
Why?
Disease Progression
4
2020
872
0.290
Why?
Liver
4
2024
1155
0.280
Why?
Diabetes Mellitus
2
2023
317
0.280
Why?
Papillomavirus Vaccines
2
2021
69
0.270
Why?
Genital Neoplasms, Female
2
2018
49
0.270
Why?
Anus Neoplasms
2
2018
25
0.270
Why?
Cell Proliferation
4
2021
1027
0.270
Why?
Metaplasia
2
2019
15
0.270
Why?
Antigens, CD
2
2019
215
0.260
Why?
Diagnosis, Differential
8
2020
1045
0.260
Why?
Prostatic Neoplasms
1
2010
400
0.250
Why?
Colitis
2
2020
50
0.250
Why?
Melanoma
2
2020
279
0.250
Why?
Polyethylene Glycols
2
2017
91
0.250
Why?
Neoplasm Grading
5
2021
126
0.240
Why?
Gold
2
2017
85
0.240
Why?
Hypertension
2
2021
568
0.240
Why?
Animals
17
2024
13465
0.240
Why?
Chi-Square Distribution
2
2016
295
0.230
Why?
Nanoparticles
2
2017
127
0.230
Why?
Proteomics
3
2017
327
0.230
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.220
Why?
Lab-On-A-Chip Devices
1
2024
10
0.220
Why?
Young Adult
7
2024
4326
0.220
Why?
Racemases and Epimerases
2
2015
18
0.220
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.220
Why?
Retrospective Studies
11
2020
6662
0.220
Why?
Carcinoma, Neuroendocrine
1
2024
25
0.220
Why?
Neuroendocrine Tumors
1
2024
23
0.220
Why?
DNA Mutational Analysis
3
2024
180
0.210
Why?
Head and Neck Neoplasms
2
2019
288
0.210
Why?
Kidney Neoplasms
2
2018
182
0.210
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
44
0.210
Why?
Chlamydia muridarum
1
2024
40
0.210
Why?
Homeodomain Proteins
1
2024
81
0.210
Why?
Lung Neoplasms
2
2019
633
0.200
Why?
Endometriosis
1
2023
15
0.200
Why?
Chlamydia Infections
1
2024
76
0.200
Why?
Gynecology
2
2020
52
0.200
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.200
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.200
Why?
CD4-Positive T-Lymphocytes
1
2024
165
0.190
Why?
Hepatocytes
2
2024
190
0.190
Why?
Fallopian Tube Neoplasms
2
2012
15
0.190
Why?
Immunotherapy
2
2021
244
0.190
Why?
Gestational Trophoblastic Disease
2
2012
2
0.190
Why?
CTLA-4 Antigen
1
2021
23
0.180
Why?
Genotype
2
2021
572
0.180
Why?
Estrogens
2
2023
223
0.180
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.180
Why?
Oncogene Fusion
1
2021
4
0.180
Why?
PTEN Phosphohydrolase
3
2020
55
0.180
Why?
Leiomyosarcoma
1
2021
22
0.180
Why?
Transcription Factors
3
2020
566
0.180
Why?
Diabetes, Gestational
1
2021
52
0.180
Why?
Cancer Vaccines
1
2021
78
0.170
Why?
Carcinosarcoma
2
2017
18
0.170
Why?
Infant, Small for Gestational Age
1
2020
35
0.170
Why?
Carcinoma, Papillary
1
2020
51
0.170
Why?
Neoplasms, Experimental
1
2020
112
0.170
Why?
Carcinoma, Transitional Cell
1
2020
54
0.160
Why?
Pregnancy in Diabetics
1
2020
25
0.160
Why?
Colonic Neoplasms
1
2021
163
0.160
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.160
Why?
Dermatology
1
2020
53
0.160
Why?
Carcinoma, Lewis Lung
1
2019
10
0.160
Why?
Radiotherapy
1
2020
129
0.160
Why?
Placenta Diseases
1
2019
15
0.160
Why?
Pregnancy Complications, Neoplastic
1
2019
24
0.160
Why?
Premature Birth
1
2021
150
0.160
Why?
Carcinoma, Renal Cell
2
2018
112
0.160
Why?
Skin Diseases
1
2020
116
0.160
Why?
Melanoma, Experimental
1
2019
34
0.160
Why?
Hepatic Veno-Occlusive Disease
1
2019
11
0.160
Why?
Odds Ratio
3
2015
568
0.160
Why?
DNA Polymerase II
1
2019
9
0.150
Why?
T-Lymphocytes
1
2021
327
0.150
Why?
Hodgkin Disease
1
2019
49
0.150
Why?
DNA Mismatch Repair
1
2019
18
0.150
Why?
Fetal Diseases
1
2019
63
0.150
Why?
Monocytes
1
2019
129
0.150
Why?
Sarcoma
1
2020
70
0.150
Why?
Inflammation
2
2020
644
0.150
Why?
Pregnancy
7
2021
2670
0.150
Why?
Urinary Bladder Neoplasms
1
2020
165
0.150
Why?
CD8-Positive T-Lymphocytes
1
2019
131
0.150
Why?
Methionine Adenosyltransferase
1
2018
19
0.150
Why?
Metformin
1
2020
81
0.150
Why?
Logistic Models
3
2015
934
0.140
Why?
Nuclear Proteins
1
2020
246
0.140
Why?
Disease Models, Animal
6
2020
1481
0.140
Why?
Radiation Tolerance
1
2019
84
0.140
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.140
Why?
DNA Helicases
1
2020
150
0.140
Why?
Rhabdomyosarcoma
1
2018
12
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
41
0.140
Why?
Intestinal Mucosa
2
2020
222
0.140
Why?
Hypoglycemic Agents
1
2020
217
0.140
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
69
0.140
Why?
Pathology, Molecular
1
2017
28
0.140
Why?
Tumor Necrosis Factor-alpha
2
2019
395
0.140
Why?
Biopsy
5
2020
603
0.140
Why?
Neoplastic Cells, Circulating
1
2017
34
0.140
Why?
Osteosarcoma
1
2017
44
0.130
Why?
Pregnancy Complications
1
2021
399
0.130
Why?
Vimentin
1
2016
32
0.130
Why?
Time Factors
3
2021
2997
0.130
Why?
DNA-Binding Proteins
2
2016
426
0.130
Why?
Papillomaviridae
1
2017
105
0.130
Why?
Acetaminophen
1
2019
277
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2017
412
0.130
Why?
Gene Expression Profiling
2
2019
1108
0.130
Why?
Cadherins
1
2016
63
0.120
Why?
Viral Load
1
2016
80
0.120
Why?
Flow Cytometry
1
2017
400
0.120
Why?
Skin Neoplasms
1
2020
500
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.120
Why?
Male
11
2024
26831
0.120
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.120
Why?
Classification
1
2015
12
0.120
Why?
Colposcopy
1
2015
17
0.120
Why?
Malate Dehydrogenase
1
2014
8
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.110
Why?
Lipogenesis
1
2014
31
0.110
Why?
Cytosol
1
2014
81
0.110
Why?
World Health Organization
1
2015
58
0.110
Why?
Mice, Inbred BALB C
3
2021
310
0.110
Why?
Neoplasm, Residual
1
2015
173
0.110
Why?
Mammary Neoplasms, Experimental
1
2015
122
0.110
Why?
Histones
1
2016
316
0.110
Why?
Adolescent
4
2024
6727
0.110
Why?
Obesity
1
2022
1164
0.110
Why?
Multiple Myeloma
1
2009
3050
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2021
179
0.110
Why?
Antineoplastic Agents
2
2021
1219
0.110
Why?
Gastrointestinal Tract
1
2014
108
0.110
Why?
Intestines
1
2014
154
0.100
Why?
Cell Line, Tumor
4
2020
1435
0.100
Why?
Oncogenes
1
2013
60
0.100
Why?
Patient Selection
1
2015
266
0.100
Why?
Clusterin
1
2012
8
0.100
Why?
Membrane Proteins
1
2015
336
0.100
Why?
Pancreatic Neoplasms
1
2015
210
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1372
0.100
Why?
Histocytochemistry
1
2012
45
0.100
Why?
Risk Factors
3
2015
3953
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
24
0.100
Why?
Strongyloidiasis
1
2012
9
0.100
Why?
Follow-Up Studies
2
2016
2293
0.090
Why?
Treatment Outcome
3
2021
5484
0.090
Why?
Cytomegalovirus Infections
1
2012
36
0.090
Why?
Prednisone
1
2012
102
0.090
Why?
Vascular Endothelial Growth Factor A
1
2012
187
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.090
Why?
Teratoma
1
2011
24
0.090
Why?
Matrix Metalloproteinases
1
2011
47
0.090
Why?
Sensitivity and Specificity
3
2020
883
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
243
0.090
Why?
Phenotype
3
2019
800
0.080
Why?
Tissue Array Analysis
3
2015
46
0.080
Why?
Glucocorticoids
1
2012
238
0.080
Why?
Tumor Cells, Cultured
2
2021
448
0.080
Why?
Epigenesis, Genetic
1
2012
403
0.080
Why?
Pilot Projects
2
2023
719
0.080
Why?
Pregnancy Outcome
2
2021
250
0.080
Why?
Infant, Newborn
3
2021
2884
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
149
0.080
Why?
Necrosis
2
2024
170
0.070
Why?
Telemedicine
1
2015
493
0.070
Why?
Cell Differentiation
2
2024
673
0.070
Why?
Hysterectomy
2
2021
91
0.070
Why?
Cell Nucleus
2
2021
189
0.070
Why?
Host-Pathogen Interactions
2
2021
144
0.070
Why?
Societies, Medical
2
2019
202
0.070
Why?
Gene Expression Regulation
3
2023
1004
0.070
Why?
Neoplasms
1
2017
1301
0.070
Why?
Consensus
2
2020
191
0.070
Why?
Ventricular Pressure
1
2006
17
0.070
Why?
Isoproterenol
1
2006
55
0.070
Why?
Terminology as Topic
2
2018
71
0.060
Why?
Kaplan-Meier Estimate
2
2018
485
0.060
Why?
Serum Response Factor
1
2006
45
0.060
Why?
Combined Modality Therapy
2
2020
638
0.060
Why?
Kidney
1
2010
723
0.060
Why?
Practice Guidelines as Topic
2
2019
496
0.060
Why?
Neoplasm Metastasis
2
2018
238
0.060
Why?
Cytokines
2
2020
624
0.060
Why?
Cells, Cultured
2
2021
1586
0.060
Why?
Proportional Hazards Models
2
2017
444
0.060
Why?
Chromatography, Liquid
2
2016
240
0.060
Why?
Bilirubin
1
2024
42
0.060
Why?
Tandem Mass Spectrometry
2
2016
250
0.050
Why?
Species Specificity
1
2024
191
0.050
Why?
Heart
1
2006
361
0.050
Why?
Steroids
1
2024
60
0.050
Why?
Th1 Cells
1
2024
54
0.050
Why?
Interleukin-10
1
2024
84
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
856
0.050
Why?
Phylogeny
1
2024
234
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
65
0.050
Why?
Hemorrhage
1
2024
224
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
11
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.050
Why?
Parturition
1
2021
50
0.050
Why?
Phthalazines
1
2021
20
0.040
Why?
Remission Induction
1
2021
219
0.040
Why?
Quinazolines
1
2021
32
0.040
Why?
Lymphocyte Activation
1
2021
162
0.040
Why?
Vulva
1
2020
18
0.040
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
18
0.040
Why?
Metabolic Networks and Pathways
1
2021
93
0.040
Why?
Herb-Drug Interactions
1
2020
31
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
57
0.040
Why?
Risk
1
2021
313
0.040
Why?
Alkaline Phosphatase
1
2020
93
0.040
Why?
Piperazines
1
2021
125
0.040
Why?
Molecular Targeted Therapy
1
2021
133
0.040
Why?
Chemokines
1
2020
78
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
582
0.040
Why?
Birth Weight
1
2020
128
0.040
Why?
United States
3
2016
5225
0.040
Why?
Preoperative Period
1
2020
47
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
37
0.040
Why?
Pyrimidines
1
2021
200
0.040
Why?
Endothelium
1
2019
38
0.040
Why?
Mice, Transgenic
2
2014
563
0.040
Why?
Colon
1
2020
105
0.040
Why?
Chest Pain
1
2019
58
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
59
0.040
Why?
Receptors, Progesterone
1
2020
66
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
33
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
191
0.040
Why?
Glutamine
1
2020
176
0.040
Why?
Dyspnea
1
2019
80
0.040
Why?
Estrogen Receptor alpha
1
2020
85
0.040
Why?
Fatal Outcome
1
2019
195
0.040
Why?
Liver Function Tests
1
2019
48
0.040
Why?
Mice, Inbred Strains
1
2019
164
0.040
Why?
Drug Synergism
1
2019
148
0.040
Why?
Gestational Age
1
2020
418
0.040
Why?
Mice, Nude
1
2019
235
0.040
Why?
Imaging, Three-Dimensional
1
2019
151
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
222
0.040
Why?
Nephrectomy
1
2018
82
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.040
Why?
Lymph Node Excision
1
2019
133
0.040
Why?
Cell Lineage
1
2018
88
0.030
Why?
Ultrasonography, Prenatal
1
2019
190
0.030
Why?
Mixed Tumor, Mullerian
1
2017
3
0.030
Why?
Skin
1
2020
420
0.030
Why?
DNA Copy Number Variations
1
2018
117
0.030
Why?
Anal Canal
1
2017
27
0.030
Why?
Lymph Nodes
1
2019
252
0.030
Why?
Macrophages
1
2019
376
0.030
Why?
Disease-Free Survival
1
2017
464
0.030
Why?
Dietary Supplements
1
2020
465
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
37
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Child
2
2024
7220
0.030
Why?
Transcriptome
1
2019
367
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
55
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Diet
1
2020
588
0.030
Why?
Signal Transduction
1
2023
1707
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
83
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
122
0.030
Why?
S100 Proteins
1
2015
34
0.030
Why?
Cell Count
1
2015
144
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
66
0.030
Why?
Pressure
1
2015
103
0.030
Why?
Cell Hypoxia
1
2015
83
0.030
Why?
Drug Evaluation, Preclinical
1
2015
142
0.030
Why?
Blood Vessels
1
2015
72
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
52
0.030
Why?
Genetic Predisposition to Disease
1
2018
528
0.030
Why?
Random Allocation
1
2015
285
0.030
Why?
Immunoenzyme Techniques
1
2014
136
0.030
Why?
Prospective Studies
1
2020
2453
0.030
Why?
Radiotherapy Dosage
1
2015
253
0.030
Why?
Apoptosis
1
2020
1122
0.030
Why?
Proteome
1
2016
170
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
186
0.030
Why?
Likelihood Functions
1
2014
56
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
263
0.030
Why?
Multivariate Analysis
1
2015
602
0.030
Why?
Genes, erbB-1
1
2013
9
0.030
Why?
Vaccination
1
2016
299
0.030
Why?
Anti-Bacterial Agents
1
2019
802
0.030
Why?
Lipid Metabolism
1
2014
188
0.030
Why?
Gene Frequency
1
2013
99
0.030
Why?
Adiposity
1
2014
143
0.030
Why?
SEER Program
1
2013
103
0.030
Why?
Mesentery
1
2012
14
0.030
Why?
Communication
1
2015
257
0.020
Why?
Rural Health Services
1
2015
169
0.020
Why?
Insulin Resistance
1
2014
278
0.020
Why?
Research Design
1
2015
358
0.020
Why?
Neoplasms, Glandular and Epithelial
1
2012
42
0.020
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.020
Why?
Pregnancy Proteins
1
2012
5
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
7
0.020
Why?
Angiopoietin-2
1
2012
14
0.020
Why?
Diet, High-Fat
1
2014
237
0.020
Why?
Angiopoietin-1
1
2012
16
0.020
Why?
Socioeconomic Factors
1
2015
606
0.020
Why?
Ovary
1
2012
107
0.020
Why?
Ivermectin
1
2012
10
0.020
Why?
Antiparasitic Agents
1
2012
11
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
38
0.020
Why?
Infant
1
2020
3715
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
Algorithms
1
2015
669
0.020
Why?
RNA, Messenger
1
2014
1139
0.020
Why?
Interleukin-6
1
2012
277
0.020
Why?
Isoenzymes
1
2011
167
0.020
Why?
Crohn Disease
1
2012
114
0.020
Why?
Promoter Regions, Genetic
1
2012
474
0.020
Why?
Gene Expression
1
2012
623
0.020
Why?
Radiography
1
2011
474
0.020
Why?
Risk Assessment
1
2015
1348
0.020
Why?
Cell Line
1
2012
1030
0.020
Why?
Cohort Studies
1
2013
1551
0.020
Why?
Rats
1
2014
3180
0.020
Why?
DNA Methylation
1
2012
583
0.020
Why?
Blotting, Western
1
2006
593
0.010
Why?
Myocardium
1
2006
479
0.010
Why?
Age Factors
1
2006
1134
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description